Dcat (Drug, Chemical & Associated Technologies Association)

Dcat (Drug, Chemical & Associated Technologies Association) company information, Employees & Contact Information

Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into industry market trends, best practices, and the issues impacting the industry. Membership in the DCAT organization provides real value by offering events, programs, services, branding opportunities, and more at affordable corporate membership rates. The DCAT organization ensures that Member Companies have an appropriate forum for high-level, strategic business meetings, timely educational sessions, and essential networking opportunities by hosting DCAT Week and the DCAT Annual Dinner each year in New York City.

Company Details

Employees
40
Founded
-
Address
One Union St.,
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
dcat.org
HQ
Robbinsville, New Jersey
Looking for a particular Dcat (Drug, Chemical & Associated Technologies Association) employee's phone or email?

Dcat (Drug, Chemical & Associated Technologies Association) Questions

News

Executive Insights: What’s Next For Roche? - DCAT Value Chain Insights

Executive Insights: What’s Next For Roche? DCAT Value Chain Insights

State of the State: mRNA Product Development - DCAT Value Chain Insights

State of the State: mRNA Product Development DCAT Value Chain Insights

New Drug Approvals: What’s Trending for Small-Molecule Drugs - DCAT Value Chain Insights

New Drug Approvals: What’s Trending for Small-Molecule Drugs DCAT Value Chain Insights

US Onshoring Push for Generic Drugs - DCAT Value Chain Insights

US Onshoring Push for Generic Drugs DCAT Value Chain Insights

Bispecific ADCs: The Next Targeted Therapy? - DCAT Value Chain Insights

Bispecific ADCs: The Next Targeted Therapy? DCAT Value Chain Insights

Big Pharma & US Manufacturing Investment - DCAT Value Chain Insights

Big Pharma & US Manufacturing Investment DCAT Value Chain Insights

Advanced Mfg in Pharma: Where Does It Play? - DCAT Value Chain Insights

Advanced Mfg in Pharma: Where Does It Play? DCAT Value Chain Insights

CDMOs/CMOs & Tariffs: The Next Move - DCAT Value Chain Insights

CDMOs/CMOs & Tariffs: The Next Move DCAT Value Chain Insights

What Makes A Customer of Choice: Are Pharma Companies & Suppliers Aligned? - DCAT Value Chain Insights

What Makes A Customer of Choice: Are Pharma Companies & Suppliers Aligned? DCAT Value Chain Insights

CDMO/CMO Report: Tracking Expansions for Injectables - DCAT Value Chain Insights

CDMO/CMO Report: Tracking Expansions for Injectables DCAT Value Chain Insights

Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025 - DCAT Value Chain Insights

Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025 DCAT Value Chain Insights

State of the State: AI in Procurement: Where Does It Stand? - DCAT Value Chain Insights

State of the State: AI in Procurement: Where Does It Stand? DCAT Value Chain Insights

What’s Trending: New Drug Approvals: Biologics - DCAT Value Chain Insights

What’s Trending: New Drug Approvals: Biologics DCAT Value Chain Insights

Pfizer Making a Major Play in the Obesity Drug Market - DCAT Value Chain Insights

Pfizer Making a Major Play in the Obesity Drug Market DCAT Value Chain Insights

US-EU Strike Trade Deal: The Impact on Pharma - DCAT Value Chain Insights

US-EU Strike Trade Deal: The Impact on Pharma DCAT Value Chain Insights

Sizing Up the Blockbuster Contenders of 2025 - DCAT Value Chain Insights

Sizing Up the Blockbuster Contenders of 2025 DCAT Value Chain Insights

Novo Nordisk Announces Restructuring; Cutting 11% of Workforce - DCAT Value Chain Insights

Novo Nordisk Announces Restructuring; Cutting 11% of Workforce DCAT Value Chain Insights

CEOs, Senior Executives Highlight Mfg Expansions at the DCAT Member Company Announcement Forum - DCAT Value Chain Insights

CEOs, Senior Executives Highlight Mfg Expansions at the DCAT Member Company Announcement Forum DCAT Value Chain Insights

DCAT Week 2025 in Review: A Snapshot of DCAT’s Education Programs - DCAT Value Chain Insights

DCAT Week 2025 in Review: A Snapshot of DCAT’s Education Programs DCAT Value Chain Insights

DCAT Value Chain Insights Bonus Coverage: From DCAT Week 2025 Member Company News Roundup - DCAT Value Chain Insights

DCAT Value Chain Insights Bonus Coverage: From DCAT Week 2025 Member Company News Roundup DCAT Value Chain Insights

Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025? - DCAT Value Chain Insights

Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025? DCAT Value Chain Insights

The Push To Onshore US Pharma Manufacturing: What’s on the Table? - DCAT Value Chain Insights

The Push To Onshore US Pharma Manufacturing: What’s on the Table? DCAT Value Chain Insights

Pharma Industry-Specific Tariffs: Industry Weighs In - DCAT Value Chain Insights

Pharma Industry-Specific Tariffs: Industry Weighs In DCAT Value Chain Insights

Mid-Year Review: New Drug Approvals—Up or Down? - DCAT Value Chain Insights

Mid-Year Review: New Drug Approvals—Up or Down? DCAT Value Chain Insights

US, EU Detail Plan for Pharmaceutical Tariffs - DCAT Value Chain Insights

US, EU Detail Plan for Pharmaceutical Tariffs DCAT Value Chain Insights

DCAT Week 2025: Pharma Industry Outlook: Is There Growth or Not? - DCAT Value Chain Insights

DCAT Week 2025: Pharma Industry Outlook: Is There Growth or Not? DCAT Value Chain Insights

The Next Round in the EU–US Tariff Battle: What’s the Impact on API Supply? - DCAT Value Chain Insights

The Next Round in the EU–US Tariff Battle: What’s the Impact on API Supply? DCAT Value Chain Insights

CDMOs: Biomanufacturing Expansion Updates - DCAT Value Chain Insights

CDMOs: Biomanufacturing Expansion Updates DCAT Value Chain Insights

The Top 25 Supply Chain Organizations: Where Does Pharma Rank? - DCAT Value Chain Insights

The Top 25 Supply Chain Organizations: Where Does Pharma Rank? DCAT Value Chain Insights

The Bio/Pharma Majors: Taking the Pharma Pulse - DCAT Value Chain Insights

The Bio/Pharma Majors: Taking the Pharma Pulse DCAT Value Chain Insights

President Trump Signs Executive Order To Increase US-Based Pharma Manufacturing - DCAT Value Chain Insights

President Trump Signs Executive Order To Increase US-Based Pharma Manufacturing DCAT Value Chain Insights

Tariffs & Pharmaceuticals: US Government Takes the Next Step - DCAT Value Chain Insights

Tariffs & Pharmaceuticals: US Government Takes the Next Step DCAT Value Chain Insights

President Trump Issues Executive Order for Most-Favored Nation Drug Pricing - DCAT Value Chain Insights

President Trump Issues Executive Order for Most-Favored Nation Drug Pricing DCAT Value Chain Insights

Emerging Pharma: The Impact and Latest on Tariffs & Changing Healthcare Policy - DCAT Value Chain Insights

Emerging Pharma: The Impact and Latest on Tariffs & Changing Healthcare Policy DCAT Value Chain Insights

New Modalities & More Upsides in the Oncology Drug Market - DCAT Value Chain Insights

New Modalities & More Upsides in the Oncology Drug Market DCAT Value Chain Insights

DCAT’s Expedition Pharma: Innovation from a Patient-First Perspective - DCAT Value Chain Insights

DCAT’s Expedition Pharma: Innovation from a Patient-First Perspective DCAT Value Chain Insights

On the Rise: CDMO/CMO Expansions for Injectables - DCAT Value Chain Insights

On the Rise: CDMO/CMO Expansions for Injectables DCAT Value Chain Insights

DCAT Week: The premier gathering for the global bio/pharmaceutical manufacturing value chain - Nutraceutical Business Review

DCAT Week: The premier gathering for the global bio/pharmaceutical manufacturing value chain Nutraceutical Business Review

Tariffs, Strategies & Biotech: Where Do Things Stand? - DCAT Value Chain Insights

Tariffs, Strategies & Biotech: Where Do Things Stand? DCAT Value Chain Insights

Will New Oral GLP-1 Agonists Be the Next Market Shaker? - DCAT Value Chain Insights

Will New Oral GLP-1 Agonists Be the Next Market Shaker? DCAT Value Chain Insights

Industry Roundtable: Small-Molecule APIs - DCAT Value Chain Insights

Industry Roundtable: Small-Molecule APIs DCAT Value Chain Insights

Tariffs & Pharma: What May Be Next? - DCAT Value Chain Insights

Tariffs & Pharma: What May Be Next? DCAT Value Chain Insights

What is Next in Drug Pricing Reforms for the US? - DCAT Value Chain Insights

What is Next in Drug Pricing Reforms for the US? DCAT Value Chain Insights

Blockbuster Contenders: Drugs to Watch in 2025 - DCAT Value Chain Insights

Blockbuster Contenders: Drugs to Watch in 2025 DCAT Value Chain Insights

What Trending: Biologic-Based Drugs - DCAT Value Chain Insights

What Trending: Biologic-Based Drugs DCAT Value Chain Insights

New Drug Approvals in 2024: How Did The Industry Fare? - DCAT Value Chain Insights

New Drug Approvals in 2024: How Did The Industry Fare? DCAT Value Chain Insights

Bio/Pharma Outlook 2025: The Year Ahead - DCAT Value Chain Insights

Bio/Pharma Outlook 2025: The Year Ahead DCAT Value Chain Insights

Will the ADC Wave Continue in 2025? - DCAT Value Chain Insights

Will the ADC Wave Continue in 2025? DCAT Value Chain Insights

Radiopharmaceuticals: A Niche But Growing Sector - DCAT Value Chain Insights

Radiopharmaceuticals: A Niche But Growing Sector DCAT Value Chain Insights

CDMO/CMO Outlook: What May Be in Store for 2025 - DCAT Value Chain Insights

CDMO/CMO Outlook: What May Be in Store for 2025 DCAT Value Chain Insights

2024: The Bio/Pharma Industry’s Year in Review - DCAT Value Chain Insights

2024: The Bio/Pharma Industry’s Year in Review DCAT Value Chain Insights

CDMOs/CMOs: The Movers and Shakers of 2024 - DCAT Value Chain Insights

CDMOs/CMOs: The Movers and Shakers of 2024 DCAT Value Chain Insights

A Strong Contract ADC Market Drives Expansions in High-Potency Manufacturing - DCAT Value Chain Insights

A Strong Contract ADC Market Drives Expansions in High-Potency Manufacturing DCAT Value Chain Insights

Making the Innovation Cut: New Drug Approvals Thus Far in 2024 - DCAT Value Chain Insights

Making the Innovation Cut: New Drug Approvals Thus Far in 2024 DCAT Value Chain Insights

Manufacturing and Supply Lines: Cell & Gene Therapies - DCAT Value Chain Insights

Manufacturing and Supply Lines: Cell & Gene Therapies DCAT Value Chain Insights

Pharma’s Innovations in Green Chemistry - DCAT Value Chain Insights

Pharma’s Innovations in Green Chemistry DCAT Value Chain Insights

Bio/Pharma Watchlist: Small-Molecule Drugs - DCAT Value Chain Insights

Bio/Pharma Watchlist: Small-Molecule Drugs DCAT Value Chain Insights

Supplier Risk Management: The Double-Edged Sword - DCAT Value Chain Insights

Supplier Risk Management: The Double-Edged Sword DCAT Value Chain Insights

The CDMO/CMO & Suppliers’ Report: The Rising Strength of Tides - DCAT Value Chain Insights

The CDMO/CMO & Suppliers’ Report: The Rising Strength of Tides DCAT Value Chain Insights

Bio/Pharma’s Top 10: Biologic-Based Drugs - DCAT Value Chain Insights

Bio/Pharma’s Top 10: Biologic-Based Drugs DCAT Value Chain Insights

Big Pharma’s Manufacturing Muscle: What Major Expansions Are Underway? - DCAT Value Chain Insights

Big Pharma’s Manufacturing Muscle: What Major Expansions Are Underway? DCAT Value Chain Insights

Bio/Pharma’s Top Mergers & Acquisitions Thus Far in 2024 - DCAT Value Chain Insights

Bio/Pharma’s Top Mergers & Acquisitions Thus Far in 2024 DCAT Value Chain Insights

FDA’s Draft Guidance on Platform Technology Designation: The Mfg Impact - DCAT Value Chain Insights

FDA’s Draft Guidance on Platform Technology Designation: The Mfg Impact DCAT Value Chain Insights

Small-Molecule Drugs: Top 10 Market, Sourcing, and Supply-Chain Trends - DCAT Value Chain Insights

Small-Molecule Drugs: Top 10 Market, Sourcing, and Supply-Chain Trends DCAT Value Chain Insights

Global Pharma Industry Outlook: The Ups and Downs & Projections Near Term - DCAT Value Chain Insights

Global Pharma Industry Outlook: The Ups and Downs & Projections Near Term DCAT Value Chain Insights

Bio/Pharma Companies Ride the Strength of the Obesity Drug Market - DCAT Value Chain Insights

Bio/Pharma Companies Ride the Strength of the Obesity Drug Market DCAT Value Chain Insights

The Top 25 Supply Chain Organizations: Where Does Pharma Rank? - DCAT Value Chain Insights

The Top 25 Supply Chain Organizations: Where Does Pharma Rank? DCAT Value Chain Insights

Generics Outlook: Small Molecules and Biosimilars - DCAT Value Chain Insights

Generics Outlook: Small Molecules and Biosimilars DCAT Value Chain Insights

Continuous mRNA Manufacturing: Is It the Next Wave in Manufacturing Innovation? - DCAT Value Chain Insights

Continuous mRNA Manufacturing: Is It the Next Wave in Manufacturing Innovation? DCAT Value Chain Insights

The CDMO/CMOs Report: The Marriage of Small Molecules & Biologics - DCAT Value Chain Insights

The CDMO/CMOs Report: The Marriage of Small Molecules & Biologics DCAT Value Chain Insights

Supply Chains: Trends in Chemical Distribution - DCAT Value Chain Insights

Supply Chains: Trends in Chemical Distribution DCAT Value Chain Insights

Attending DCAT Week? Let Us Help You Spread the Word - DCAT Value Chain Insights

Attending DCAT Week? Let Us Help You Spread the Word DCAT Value Chain Insights

DCAT Announces New Board of Directors for 2023 - DCAT Value Chain Insights

DCAT Announces New Board of Directors for 2023 DCAT Value Chain Insights

DCAT Announces New Board of Directors for 2022 - DCAT Value Chain Insights

DCAT Announces New Board of Directors for 2022 DCAT Value Chain Insights

Women Leaders in Pharma Interview: Sally Macaluso, Johnson & Johnson - DCAT Value Chain Insights

Women Leaders in Pharma Interview: Sally Macaluso, Johnson & Johnson DCAT Value Chain Insights

Top Dcat (Drug, Chemical & Associated Technologies Association) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant